Opera Trading Capital Invests $977,000 in Advanced Accelerator Application SA (NASDAQ:AAAP)

Opera Trading Capital purchased a new position in shares of Advanced Accelerator Application SA (NASDAQ:AAAP) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,965 shares of the company’s stock, valued at approximately $977,000.

A number of other institutional investors have also made changes to their positions in the stock. Wells Fargo & Company MN lifted its position in shares of Advanced Accelerator Application by 81.5% during the second quarter. Wells Fargo & Company MN now owns 4,514 shares of the company’s stock worth $177,000 after purchasing an additional 2,027 shares during the last quarter. State Street Corp lifted its position in shares of Advanced Accelerator Application by 1.3% during the second quarter. State Street Corp now owns 25,995 shares of the company’s stock worth $1,014,000 after purchasing an additional 344 shares during the last quarter. PointState Capital LP bought a new position in shares of Advanced Accelerator Application during the second quarter worth about $5,247,000. Reliance Trust Co. of Delaware bought a new position in shares of Advanced Accelerator Application during the third quarter worth about $596,000. Finally, Empirical Finance LLC bought a new position in shares of Advanced Accelerator Application during the third quarter worth about $265,000. 42.28% of the stock is owned by hedge funds and other institutional investors.

Several equities analysts have recently commented on AAAP shares. BidaskClub cut shares of Advanced Accelerator Application from a “hold” rating to a “sell” rating in a research report on Thursday, January 11th. Zacks Investment Research raised shares of Advanced Accelerator Application from a “hold” rating to a “buy” rating and set a $91.00 price target on the stock in a research report on Wednesday, November 1st. ValuEngine raised shares of Advanced Accelerator Application from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. JPMorgan Chase & Co. lowered shares of Advanced Accelerator Application from an “overweight” rating to a “neutral” rating and set a $82.00 price objective on the stock. in a research note on Monday, November 20th. Finally, JMP Securities lowered shares of Advanced Accelerator Application from an “outperform” rating to a “market perform” rating in a research note on Monday, October 30th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. Advanced Accelerator Application presently has an average rating of “Hold” and a consensus target price of $69.80.

Shares of Advanced Accelerator Application SA (AAAP) opened at $81.63 on Thursday. Advanced Accelerator Application SA has a 12 month low of $35.11 and a 12 month high of $82.74.

Advanced Accelerator Application (NASDAQ:AAAP) last announced its quarterly earnings results on Friday, November 17th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.43). Advanced Accelerator Application had a negative net margin of 43.93% and a negative return on equity of 20.59%. sell-side analysts predict that Advanced Accelerator Application SA will post -0.89 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was posted by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://weekherald.com/2018/02/15/opera-trading-capital-takes-977000-position-in-advanced-accelerator-application-sa-aaap.html.

Advanced Accelerator Application Company Profile

Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.

Institutional Ownership by Quarter for Advanced Accelerator Application (NASDAQ:AAAP)

Receive News & Ratings for Advanced Accelerator Application Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Application and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply